Skip to main content

Patient Support Line 1-844-638-7222, Monday-Friday, 8:00 AM – 8:00 PM ET, excluding holidays.

Couple talking to their doctor, with Pluvicto V in the background

About
mCRPC

Considering your next mCRPC treatment

There is a lot to process when hearing your, or a loved one’s, prostate cancer has spread.

About mCRPC: metastatic Castration-Resistant Prostate Cancer

There are different types of prostate cancer that you may have heard of:

  • Prostate cancer that has spread outside the prostate is called metastatic

  • Prostate cancer that is no longer responding to hormone treatment that lowers testosterone is called castration-resistant
     

When your cancer is metastatic and castration-resistant, it is called mCRPC.

If you have mCRPC, you may also be PSMA+ (prostate-specific membrane antigen positive)

You can find out if you are PSMA+ with a PSMA-PET scan
Icon of PET scan

A PSMA-PET scan is an imaging test that allows your doctor to check for PSMA+ cells, including prostate cancer cells, in your body.

Want to see how other people are navigating conversations with their doctors?*

Watch Mike and Lyse discuss how patients and doctors navigate treatment together.

*Patient and health care provider experience may vary. Mike, Lyse, and Dr Beckermann were compensated for their participation in this video.

Interested in receiving information about PLUVICTO?

PLUVICTO® Pulse is a series of emails that helps you talk to your doctor about PLUVICTO.

PET, positron emission tomography.